Oppenheimer, the brokerage firm, has recently decreased the rating on Somaxon Pharma (SOMX). They lowered the rating from Outperform to Perform. The brokerage firm believes the company is on the downswing and there could be potential savings or capital preservation in selling the stock now. Shares of SOMX traded higher by 0.54% or $0.005/share to $0.92. In the past year, the shares have traded as low as $0.86 and as high as $4.49. On average, 578295 shares of SOMX exchange hands on a given day and today's volume is recorded at 184618.
